Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer

Clinical trial NCT00303628 · TERMINATED

Trial details

NCT number: NCT00303628
Sponsor: ECOG-ACRIN Cancer Research Group
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma of the Rectum Stage II Rectal Cancer Stage III Rectal Cancer

Start date: 2006-05-11
Primary completion: 2015-04-01
Enrollment: 355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.